HSV-1 amplicon peptide display vector

被引:11
|
作者
Spear, MA
Schuback, D
Miyata, K
Grandi, P
Sun, F
Yoo, L
Nguyen, A
Brandt, CR
Breakefield, XO
机构
[1] Univ Calif San Diego, UCSD Med Ctr, UCSD Canc Ctr, Gene Therapy Program, La Jolla, CA 92093 USA
[2] Massachusetts Gen Hosp, Dept Neurol, Mol Neurogenet Unit, Boston, MA USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Univ Wisconsin, Dept Opthalmol, Madison, WI USA
关键词
gene therapy; herpes simplex virus type-1; amplicon; phage display; peptide expression vector; vector targeting; glioblastoma multiforme;
D O I
10.1016/S0166-0934(02)00193-3
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
There are significant uses for expressing foreign peptide epitopes in viral surface attachment proteins in terms of investigating viral targeting, biology, and immunology. HSV-1 attachment, followed by fusion and entry, is mediated in large part by the binding of viral surface glycoproteins to cell surface receptors, primarily through heparan sulfate (HS) glycosaminoglycan residues. We constructed a HSV-1 amplicon plasmid (pCONGA) carrying the gC primary attachment protein gene with unique restriction sites flanking the HS binding domain (HSBD) (residues 33-176) to allow rapid, high efficiency substitution with foreign peptide domains. To test this system, a His tag with an additional unique restriction site (for selection and assay digests) was recombined into the pCONGA HSBD site to create pCONGAH. Infection of pCONGAH transfected Vero cells with HSV-1 helper virus (gCDelta2-3 or hrR3) produced His-modified gC as demonstrated by western blot analysis with co-localization of anti-gC and anti-His tag antibodies to a protein of appropriate molecular weight (50 kd). As CONGA and CONGAH amplicons carry a GFP transgene and the gCDelta2-3 and hrR3 viruses carry a lacZ transgene, vector stocks produced from 1 x 10(5) Vero cells could be titered for competent vector on cell monolayers and were demonstrated to contain 2 x 10(5) amplicon vector transducing units (t.u.)/ml and 1 x 10(7) virus t.u./ml. As the amplicon plasmids also contain the neomycin resistance gene (neo(r)), long term vector producer cell lines were created using 6418 selection. This amplicon system provides means to rapidly and efficiently generate HSV-1 amplicon and viral vector expressing surface attachment proteins modified with different peptide epitopes for investigational and therapeutic uses, with the advantages of an amplicon plasmid that can be used with interchangeable helper virus vectors, is designed specifically for easy manipulation, and carries GFP and neo(r) transgenes for marker and selection functions. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:71 / 79
页数:9
相关论文
共 50 条
  • [31] Present and future of herpes simplex virus type 1 (HSV-1)-based amplicon vectors
    Epstein, AL
    PATHOLOGIE BIOLOGIE, 2005, 53 (01): : 1 - 3
  • [32] Hsv/aav hybrid amplicon vectors:: Is AAV rep expression compatible with efficient HSV-1 DNA replication?
    Fraefel, C
    Baechi, T
    Bittermann, AG
    Meyer, C
    Heister, T
    Ackermann, M
    CANCER GENE THERAPY, 2004, 11 (12) : 845 - 845
  • [33] Assessment of a cellular vaccine consisting of dendritic cells transduced with HSV-1 amplicon vectors
    Nunez, R
    Fraefel, C
    Suter, M
    Ackermann, M
    FASEB JOURNAL, 2002, 16 (05): : A1231 - A1231
  • [34] Construction of HSV-1 HF based replication defective vector
    Xiang, Li
    Liu, Xinjing
    Liu, Huitao
    Han, Zhiqiang
    Lu, Jiameng
    Xu, Yuming
    LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION, 2011, 8 (03): : 547 - 553
  • [35] HSV-1 amplicon vectors are an efficient gene transfer system for skeletal muscle cells
    Wang, Yaming
    CURRENT GENE THERAPY, 2006, 6 (03) : 371 - 381
  • [36] HSV-1 based amplicon vectors as an alternative system for the expression of functional HCV proteins
    Tsitoura, Eliza
    Georgopoulou, Urania
    Mavromara, Penelope
    CURRENT GENE THERAPY, 2006, 6 (03) : 393 - 398
  • [37] Universal HSV-1 amplicon vectors for imaging-guided gene therapy.
    Winkeler, A
    Kummer, C
    Dittmar, C
    Galldiks, N
    Bauer, B
    Wienhard, K
    Heiss, WD
    Jacobs, AH
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 34P - 34P
  • [39] IMMUNIZATION AGAINST HSV-1 KERATITIS WITH A SYNTHETIC GD PEPTIDE
    HEILIGENHAUS, A
    WELLS, PA
    FOSTER, CS
    EYE, 1995, 9 : 89 - 95
  • [40] HSV-1 amplicon viral vector-mediated gene transfer to human bone marrow-derived mesenchymal stem cells
    I A W Ho
    K Y W Chan
    L Miao
    W S N Shim
    C M Guo
    P Cheang
    K M Hui
    P Y P Lam
    Cancer Gene Therapy, 2008, 15 : 553 - 562